Table 2 |
|||||||||||||
|
Crude and RDS-adjusted seroprevalence of infectious diseases among study participants |
|||||||||||||
| Doña Ana County, NM |
Ciudad Juárez, MX |
El Paso, TX |
Crude % p-value |
||||||||||
|
|
|||||||||||||
| Positive |
Total* |
Crude % |
RDS % |
Positive |
Total |
Crude % |
RDS % |
Positive |
Total |
Crude % |
RDS % |
||
|
|
|||||||||||||
| HAV |
66 |
97 |
68.0 |
- |
- |
- |
- |
- |
105 |
148 |
70.9 |
73.0 |
0.740 a |
| HBV |
56 |
94 |
59.6 |
- |
171 |
203 |
84.2 |
88.3 |
74 |
137 |
54.8 |
48.6 |
< .0001 b |
| HCV |
76 |
95 |
80.0 |
- |
194 |
203 |
95.6 |
98.7 |
122 |
147 |
83.0 |
76.4 |
< .0001a |
| HIV |
1 |
100 |
1.0 |
- |
6 |
203 |
3.0 |
2.1 |
9 |
155 |
5.8 |
10.0 |
0.109b |
| Syphilis |
3 |
100 |
3.0 |
- |
7 |
193 |
3.6 |
4.0 |
8 |
150 |
5.3 |
9.9 |
0.605a |
|
|
|||||||||||||
|
*Total excludes participants whose sample was either insufficient or rejected for testing. a Chi-square test of independence used to observe differences among crude seroprevalence across sites. b Fisher's Exact method used to run test of independence due to > 20% of cells with less than 5 observations. |
|||||||||||||
|
Baumbach et al. Harm Reduction Journal 2008 5:33 doi:10.1186/1477-7517-5-33 |
|||||||||||||